Recap: ADC Therapeutics Q4 Earnings

ADC Therapeutics ADCT reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

ADC Therapeutics beat estimated earnings by 54.65%, reporting an EPS of $-0.39 versus an estimate of $-0.86.

Revenue was up $17.01 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.33 which was followed by a 3.32% increase in the share price the next day.

Here's a look at ADC Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.